Lein was founded in May 2003 and their first application is a portable optical glucose sensor for people with diabetes.
Lein's innovative eye scanning technique involves a low power beam of light which is shone into the eye, and the reflected light used to evaluate the health of the individual. A key use of the device is the non-invasive measurement of blood glucose levels in people with diabetes, a procedure currently performed by patients taking a pin prick of blood 3-4 times a day.
Lein is keen to take a significant proportion of the $7bn market for blood glucose monitoring.